Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD)
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Predictors of survival in metastatic melanoma patients with leptomeningeal disease (LMD)
Authors
Keywords
Melanoma, Leptomeningeal disease, Intrathecal therapy, Targeted therapy, Immunotherapy
Journal
JOURNAL OF NEURO-ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2019-03-08
DOI
10.1007/s11060-019-03121-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Evaluating Circulating Tumor DNA From the Cerebrospinal Fluid of Patients With Melanoma and Leptomeningeal Disease
- (2018) Leomar Y Ballester et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non–Small-Cell Lung Cancer
- (2018) Kathryn C. Arbour et al. JOURNAL OF CLINICAL ONCOLOGY
- Rapid resolution of leptomeningeal disease with targeted therapy in a metastatic melanoma patient
- (2017) Isabella C. Glitza et al. JOURNAL OF NEURO-ONCOLOGY
- Dabrafenib plus trametinib in patients with BRAF V600 -mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial
- (2017) Michael A Davies et al. LANCET ONCOLOGY
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- Targeted treatment and immunotherapy in leptomeningeal metastases from melanoma
- (2016) M. H. Geukes Foppen et al. ANNALS OF ONCOLOGY
- Leptomeningeal metastasis: Clinical experience of 519 cases
- (2016) Jae-Won Hyun et al. EUROPEAN JOURNAL OF CANCER
- Management of leptomeningeal metastases: Prognostic factors and associated outcomes
- (2016) Jeffrey V. Brower et al. JOURNAL OF CLINICAL NEUROSCIENCE
- Evaluating Cancer of the Central Nervous System Through Next-Generation Sequencing of Cerebrospinal Fluid
- (2016) Elena I. Pentsova et al. JOURNAL OF CLINICAL ONCOLOGY
- Pembrolizumab for patients with melanoma or non-small-cell lung cancer and untreated brain metastases: early analysis of a non-randomised, open-label, phase 2 trial
- (2016) Sarah B Goldberg et al. LANCET ONCOLOGY
- Vemurafenib in leptomeningeal carcinomatosis from melanoma
- (2016) Charalampos S. Floudas et al. MELANOMA RESEARCH
- Melanoma central nervous system metastases: current approaches, challenges, and opportunities
- (2016) Justine V. Cohen et al. Pigment Cell & Melanoma Research
- Prolonged survival of a patient with metastatic leptomeningeal melanoma treated with BRAF inhibition-based therapy: a case report
- (2015) Dae Won Kim et al. BMC CANCER
- Intrathecal Interleukin-2 for Melanomatous Meningitis
- (2014) Nicole A. Shonka et al. JOURNAL OF CLINICAL ONCOLOGY
- Combined BRAF (Dabrafenib) and MEK Inhibition (Trametinib) in Patients WithBRAFV600-Mutant Melanoma Experiencing Progression With Single-Agent BRAF Inhibitor
- (2014) Douglas B. Johnson et al. JOURNAL OF CLINICAL ONCOLOGY
- Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study
- (2014) Masaaki Yamamoto et al. LANCET ONCOLOGY
- How Steroids Steer T Cells
- (2014) Claude Libert et al. Cell Reports
- Vemurafenib for Leptomeningeal Melanomatosis
- (2013) Niklas Schäfer et al. JOURNAL OF CLINICAL ONCOLOGY
- Leptomeningeal Carcinomatosis in Non–Small-Cell Lung Cancer Patients: Impact on Survival and Correlated Prognostic Factors
- (2013) Su Jin Lee et al. Journal of Thoracic Oncology
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Leptomeningeal carcinomatosis: Prognostic value of clinical, cerebrospinal fluid, and neuroimaging features
- (2012) Jose-Alberto Palma et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Ipilimumab in patients with melanoma and brain metastases: an open-label, phase 2 trial
- (2012) Kim Margolin et al. LANCET ONCOLOGY
- Comparative study of YKL-40, S-100B and LDH as monitoring tools for Stage IV melanoma
- (2011) Friederike Egberts et al. EUROPEAN JOURNAL OF CANCER
- Prognostic factors for survival in melanoma patients with brain metastases
- (2010) Michael A. Davies et al. CANCER
- Leptomeningeal Disease
- (2010) Morris D. Groves NEUROSURGERY CLINICS OF NORTH AMERICA
- Targeted Therapy for Melanoma: A Primer
- (2010) Michael A. Davies et al. Surgical Oncology Clinics of North America
- Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
- (2009) Eric L Chang et al. LANCET ONCOLOGY
- Leptomeningeal carcinomatosis
- (2008) Jordi Bruna et al. CANCER
- Brain and leptomeningeal metastases from cutaneous melanoma: Survival outcomes based on clinical features
- (2008) Jeffrey J. Raizer et al. NEURO-ONCOLOGY
- Prognostic factors and outcomes in patients with leptomeningeal melanomatosis
- (2008) Laura Harstad et al. NEURO-ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started